Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPG (Implantable Provider Group) is a leading provider of Device Benefit Management (DBM) solutions for the healthcare industry. The company specializes in managing the cost and delivery of high-cost implantable medical devices across various specialties, including cardiology, neurology, and orthopedics. By partnering with health plans, hospitals, and manufacturers, IPG streamlines the procurement and billing processes to provide greater transparency and cost-predictability. Their model is designed to support value-based care initiatives by reducing the financial and administrative burden associated with surgical implants. In 2022, IPG was acquired by Cardinal Health for approximately $450 million to enhance Cardinal's suite of specialized healthcare services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Implantable Provider Group.